Citations 2
Gastroblastoma of the Pylorus: A Case Report and Review of the Literature
McCammon, Nathan , Dunn, Andrew , Graham, Rondell P. , McHugh, Jonathan B. , Lamps, Laura, Bresler, Scott C. , Cole, Thomas, Rottmann, Douglas , Graham, Rondell P , Cole, Thomas
International Journal of Surgical Pathology | February 24, 2023 | Volume: 31 | Issue: 8 | Pages: 1516-1521
Gastroblastoma is an extremely rare biphasic tumor that typically occurs in the stomach in patients between the ages of 10 and 30. Only 16 cases have been reported previously. These tumors are important to diagnose and distinguish from more aggressive neoplasms; although numbers are small, prognosis appears excellent overall with complete excision, with only occasional metastasis and/or local recurrence. We report a case of gastroblastoma in a 26-year-old male arising from the pylorus and extending through the first and second portions of the duodenum. This is the first case to be reported from this specific location.
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Merryman, Reid W. , Zinzani, Pier Luigi , Carlo‐Stella, Carmelo , Ansell, Stephen M. , Perales, Miguel-Angel, Avigdor, Abraham, Halwani, Ahmad , Houot, Roch, Marchand, Tony , Dhédin, Nathalie , Lescaut, W., Thiebaut‐Bertrand, Anne , François, Sylvie, Stamatoullas‐Bastard, Aspasia, Rohrlich, Pierre-Simon, Wallet, Hélène Labussière, Castagna, Luca , Santoro, Armando , Bachanová, Veronika , Bresler, Scott C., Kim, Harim , Pesek, Emily, Chammas, Marie J, Reynolds, Carol, Ho, Vincent T., Antin, Joseph H., Soiffer, Robert J. , Armand, Philippe , Kim, Haesook T. , Houot, Roch , Rohrlich, Pierre‐Simon , Bresler, Scott C. , Srivastava, Amitabh , Reynolds, Carol, Antin, Joseph H. , Ritz, Jerome , Bachanova, Veronika , Zinzani, Pier Luigi , Santoro, Armando , Castagna, Luca , Carlo-Stella, Carmelo , Merryman, Reid W
Blood | January 10, 2017 | Volume: 129 | Issue: 10 | Pages: 1380-1388
Key Points HSCT after PD-1 blockade is feasible, although may be associated with increased early immune toxicity. PD-1 blockade may cause persistent depletion of PD1+ T cells and alterations in T-cell differentiation impacting subsequent treatment.